Jaypee Brothers
In Current Chapter
In All Chapters
X
Clear
X
GO
Normal
Sepia
Dark
Default Style
Font Style 1
Font Style 2
Font Style 3
Less
Normal
More
Update in Interventional Cardiology
Ashwin B Mehta, Nihar Mehta, Rahul Chhabria
CHAPTER 1:
Vascular Access
FEMORAL ACCESS
ANATOMY OF FEMORAL ARTERY AND IDEAL LOCATION OF PUNCTURE
PRACTICAL LANDMARKS FOR PUNCTURE
COMPLICATIONS
Closure Devices
Collagen Plug Device: Angio-Seal
Transcatheter Aortic Valve Implantation (TAVI)
Radial Access
Anatomy of Radial Artery
Modified Allen's Test (Fig. 3)
Plethysmography and Pulse Oxymetry for Evaluation of Palmar Arch
Puncture Technique
Right or Left Radial Approach
Ulnar Approach
COMPLICATIONS
CHAPTER 2:
Coronary Stents: Evolution and Advances
PLAIN OLD BALLOON ANGIOPLASTY
FIRST-GENERATION STENTS
SECOND-GENERATION DES
THIRD-GENERATION STENTS
Bioabsorbable Scaffolds
Evolution of Bioabsorbable Stents
MAGMARIS STENT—PREVIOUS STUDIES
CONCLUSION
CHAPTER 3:
Slender Transradial Interventions
INTRODUCTION
DIAMETER OF RADIAL ARTERIES AND DEFINITION OF SMALL RADIAL ARTERY
Challenge of Transradial Interventions in Patients with Small Radial Arteries
SHEATH-SIZING PROTOCOL BASED ON DIAMETER OF ACCESS ARTERY
New Techniques for Overcoming the Challenge of Small Access Arteries
MARS PILOT REGISTRY: MINIMIZING ACCESS ARTERY OCCLUSIONS21
Study Findings
CHAPTER 4:
Left Main Coronary Intervention
INTRODUCTION
INITIAL EXPERIENCE WITH PCI
TRIALS COMPARING PCI WITH CABG
ROLE OF IMAGING AND FFR
OSTIAL LM PCI
MANAGEMENT OF LM BIFURCATION
WHAT GUIDELINES SAY?
RECENTLY PUBLISHED TRIALS
CONCLUSION
CHAPTER 5:
Current Approach to Chronic Total Occlusions
INTRODUCTION
CLINICAL AND LESION-RELATED FACTS
Setting up for a CTO Case
Access and Dual Angiography
Rationale of the Approaches
Antegrade Wire Manipulations and Techniques
Wire Escalation: The Last Decade
Wire Escalation: Current Strategy
Parallel Wire Techniques
Strategy Based on Wire Advancement
Retrograde Approach
CHAPTER 6:
Ostial Lesions
INTRODUCTION
PECULIARITIES AND CHALLENGES OF OSTIAL LESION INTERVENTIONS1-3
ACCESS
FLUOROSCOPIC VIEWS (SEE figs. 2 and 3)
EQUIPMENT GUIDING CATHETERS
WIRES
LESION PREPARATION
STENT POSITIONING
How to Properly Position the Aorto-ostial Stent?
Stent Deployment
SPECIAL SITUATIONS IN OSTIAL LESIONS
RECOMMENDED READING
CHAPTER 7:
Coronary Bifurcation Lesions
INTRODUCTION
DEFINITIONS AND CLASSIFICATIONS
ANATOMICAL CONSIDERATIONS
STENTING STRATEGY IN BIFURCATION LESIONS—ONE OR TWO STENTS?
PROVISIONAL SIDE BRANCH STENTING STRATEGY
EVIDENCE
STEPS28
ELECTIVE DOUBLE-STENT STRATEGY
INDICATIONS
TECHNIQUES33
DEDICATED BIFURCATION STENT SYSTEM
WHAT SHOULD AN IDEAL DEDICATED BIFURCATION STENT ACHIEVE?48
CATEGORIES OF DEDICATED BIFURCATION STENTS
CHALLENGES OF USING DEDICATED BIFURCATION STENT SYSTEMS49
ADVANTAGES OF USING DEDICATED BIFURCATION STENT SYSTEMS
PRELIMINARY CLINICAL RESULTS WITH DEDICATED BIFURCATION STENTS
SUMMARY
CHAPTER 8:
Calcified Lesions
INTRODUCTION
PROCEDURE PLANNING
ASSESSMENT OF CAC
CORONARY ANGIOGRAPHY
CORONARY INTRAVASCULAR ULTRASOUND
OPTICAL COHERENCE TOMOGRAPHY
FRACTIONAL FLOW RESERVE
RISK ASSESSMENT
TREATMENT OF CALCIFIED SIGNIFICANT NARROWING
LESION PREPARATION
DEBULKING DEVICES
Cutting Balloon
Device
Mechanism of Action
Clinical Evidence
Scoring Balloon
Device
Mechanism of Action
Clinical Evidence
Complications11,23
Rotational Atherectomy
Device
Mechanism of Action
Clinical Evidence
Complications25
Orbital Atherectomy
Device
Mechanism of Action
Clinical Evidence
Rotational Atherectomy vs Orbital Atherectomy
Laser Atherectomy
Device
Mechanism of Action
Clinical Evidence
Current Status of Atherectomy Devices
CONCLUSION
CHAPTER 9:
PCI in Patients Post Coronary Artery Bypass Grafts
INTRODUCTION
RECURRENCE OF ISCHEMIA IN POST CABG PATIENTS
EARLY (IMMEDIATE POSTOPERATIVE PERIOD BEFORE DISCHARGE FROM HOSPITAL)
INTERMEDIATE (1 MONTH TO 1 YEAR)
LATE (MORE THAN 1 YEAR)
ACUTE MYOCARDIAL INFARCTION
TREATING RECURRENT ISCHEMIA
PERCUTANEOUS CORONARY INTERVENTIONS
NATIVE VESSEL PCI
Aorto-ostial Lesions
Native Vessel CTO
GRAFT INTERVENTIONS
Vein Graft Interventions
SVG STENTING
Covered Stents
Embolic Protection Devices (Table 1)
Distal Occlusion/Aspiration System: The PercuSurge GuardWire (Figs. 8A and B)
Distal Filtration System (FilterWire EX) (Fig. 9)
Proximal Occlusion/Aspiration System Proxis System (Fig. 11)
Selection of EPD
Technical Aspects of SVG PCI27
Intravascular Ultrasound (IVUS) in SVG PCI
SVG CTO
Adjunctive Pharmacotherapy
GP IIb/IIIa Inhibitors
Vasodilators
ARTERIAL GRAFT INTERVENTIONS
LIMA Graft Intervention
LIMA Graft Restenosis after PTCA
Technical Aspects of LIMA Graft Intervention27
TAKE HOME MESSAGE
CHAPTER 10:
Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction
INTRODUCTION
PRIMARY ANGIOPLASTY
Challenges to Primary Angioplasty
Logistic Challenges
Pharmacoinvasive Strategy
ANTIPLATELET DRUGS, WHICH TO CHOOSE?
Radial versus Femoral Access
Crossing the Lesion
Percutaneous Coronary Intervention of Nonculprit Vessel
Aspiration Thrombectomy (Flowchart 2)
Glycoprotein (GP) IIb/IIIa Inhibitors
CHOICE OF ANTICOAGULANT: BIVALIRUDIN VERSUS UNFRACTIONATED HEPARIN
Direct Stenting versus Predilation
Balloon versus Stents
Periprocedural Thrombotic Complications
Intra-aortic Balloon Pump
NONADHERENCE TO P2Y12 INHIBITORS
EDUCATE Study
CONCLUSION
CHAPTER 11:
High-Risk Percutaneous Coronary Interventions
DEFINING HIGH-RISK PCI CRITERIA
MECHANICAL CIRCULATORY SUPPORT DEVICES (FIGs. 1 and 2, TABLEs 2 and 3)
MAINTENANCE OF END-ORGAN PERFUSION
OPTIMIZATION OF MYOCARDIAL PERFUSION
INTRA-AORTIC BALLOON COUNTER PULSATION (IABP)
EVIDENCE-BASED OBSERVATIONAL AND REGISTRY DATA
EVIDENCE BASED RANDOMIZED TRIAL DATA
IABP-SHOCK II (INTRA-AORTIC BALLOON PUMP IN CS II) TRIAL
Impella Device
TANDEM HEART
EXTRACORPOREAL MEMBRANE OXYGENATION
CONCLUSION
CHAPTER 12:
Complications during Percutaneous Coronary Interventions
CORONARY ARTERY COMPLICATIONS
Slow/No Reflow
Coronary and Stent Thrombosis
Optimal Anticoagulation
Coronary Perforation
The Following are Balloon-Expandable Covered Stents
Coronary Dissection and Abrupt Closure
Arrhythmias
VASCULAR ACCESS SITE RELATED COMPLICATIONS
Access Site Bleeding and Hematoma
Attaining Hemostasis
Retroperitoneal Bleeding
Prevention of Complications
How to Reduce Transfemoral Access Complications?
Radial Artery Access
Prevention of Complications
How to Reduce Transradial Access Complications?
OTHER COMPLICATIONS
Contrast-Induced Nephropathy
Cerebrovascular Events
Radiation Toxicity
Retained PCI Equipment Components
Cholesterol Emboli
CHAPTER 13:
Intracoronary Assessment: Role of IVUS and OCT
INTRODUCTION
LIMITATIONS OF CORONARY ANGIOGRAM
IVUS
Basic Interpretation of IVUS
Uses
Pre-PCI Assessment
Post-PCI Assessment
IVUS for Specific Lesion Subsets
Left Main
Bifurcation Stenting
ACS
Ostial Lesions
Identifying Vulnerable Plaque
Recommendations for IVUS
Recent Advances in IVUS by using Reconstruction with Specific Algorithms
OCT
Basic OCT Image Interpretation
Uses of OCT
Pre-PCI Assessment
Post-PCI
Determine Stent Expansion and Apposition
Rule Out Geographical Miss
Follow-up Assessment of Stent Strut Coverage and ISA (Incomplete Stent Apposition)
Assessment of Biovascular Scaffolds
Limitations of OCT
Guidelines
CHAPTER 14:
Role of FFR in Evaluation of Coronary Artery Disease
INTRODUCTION
TECHNIQUE OF FFR ESTIMATION
COMMON PITFALLS DURING FFR ESTIMATION
FFR IN INTERMEDIATE LESION
FFR IN MULTIVESSEL DISEASE
FFR IN LEFT MAIN DISEASE
FFR IN SERIAL LESION AND DIFFUSE DISEASE
FFR IN BIFURCATION LESIONS
FFR IN ACUTE CORONARY SYNDROME (ACS)
FFR IN GRAFT DISEASE
IMPACT OF COLLATERALS ON THE ASSESSMENT OF FFR
SUMMARY
CHAPTER 15:
Cardiac MRI and Cardiac CT: Indispensable Tools for the Diagnosis of Coronary Artery Disease
INTRODUCTION
CARDIAC CT
CA SCORING
CORONARY ANGIOGRAPHY (CCA)
To Rule Out Coronary Artery Disease
Stents
Plaque Evaluation
Perfusion11
Following Bypass Surgery
Cardiac MRI (CMR)
Coronary Arteries
Perfusion
Viability Imaging
CONCLUSION
CHAPTER 16:
Radionuclide Studies in Cardiology
INTRODUCTION
MYOCARDIAL ISCHEMIA
Principle of MPS
Preparation for MPS
Procedure
MYOCARDIAL VIABILITY
MYOCARDIAL INNERVATION
CONCLUSION
CHAPTER 17:
Balloon Mitral Valvuloplasty
INTRODUCTION
Keywords
ANATOMIC CONSIDERATIONS
BALLOON MITRAL VALVULOPLASTY
Historical Aspect
Indications and Recommendations for Percutaneous Balloon Mitral Valvuloplasty (BMV)
Contraindications
PERIPROCEDURAL CARE
Preprocedural Planning
Role of Echocardiography in BMV: Valve Assessment and Case Selection
PATIENT PREPARATION
TECHNIQUES
Approach
Choice of Technique
Inoue Balloon Technique
Vascular Access
Transseptal Puncture
Equipments for Septal Puncture
Dilatation of IAS Puncture Site
Selection of Balloon Catheter
Crossing the Mitral Valve
BMV IN DIFFICULT SCENARIOS
BMV in LA/LAA Clot
BMV in Giant LA/IAS Aneurysm
BMV in Severe Subvalvular Disease
BMV in IVC Interruption/IVC Anomalies through IJV Approach
BMV in Juvenile Mitral Stenosis
BMV in Pregnancy
COMPLICATIONS OF BMV
Pericardial Effusion/Tamponade
Acute Mitral Regurgitation
Stroke, Embolism
Residual Atrial Septal Defect
Immediate Results of BMV
Long-term Results
CONCLUSION
CHAPTER 18:
Pulmonary and Aortic Balloon Valvuloplasty
PULMONARY BALLOON VALVULOPLASTY
CLINICAL FEATURES
DIFFERENTIAL DIAGNOSIS
MANAGEMENT
SALIENT FEATURES
BALLOON AORTIC VALVULOPLASTY
Introduction
Indications
INDICATIONS FOR BAV IN PATIENTS < 21 YEARS AGE
INDICATIONS FOR BAV IN ADULTS
PRE-CATHETERIZATION PLANNING
CONSENT
PROCEDURE
Anesthesia
Access
Arterial Access
Venous Access
Catheters and Wires
Balloon
Balloon Length
Balloon Diameter
Balloon Pressure
Steps (Retrograde Approach)
Variations in Procedure
Double Balloon Technique
ANTE-GRADE APPROACH
Post-Procedure Care
Complications
SUMMARIZING
CHAPTER 19:
Transcatheter Aortic Valve Replacement (TAVR)—Current Status
INTRODUCTION
INDICATIONS OF AORTIC VALVE REPLACEMENT (SAVR OR TAVR)3 (Table 1)
INDICATIONS FOR TAVR4 (Table 2)
Prerequisites for TAVR
RISK ASSESSMENT
CONTRAINDICATIONS FOR TAVR (Table 4)
Types of TAVR Valves
Approaches for TAVR (Figs. 4A to E)
PATIENT SPECIFIC SELECTION OF TAVR VALVE
CURRENT STATUS OF EVIDENCE
PROHIBITIVE SURGICAL RISK (INOPERABLE) GROUP: TAVR VERSUS MEDICAL MANAGEMENT
THE COREVALVE PIVOTAL EXTREME RISK ILEOFEMORAL STUDY19
HIGH SURGICAL RISK GROUP: TAVR VERSUS SAVR
COREVALVE PIVOTAL HIGH RISK STUDY22
INTERMEDIATE SURGICAL RISK GROUP: TAVR VERSUS SAVR
LOW SURGICAL RISK GROUP: TAVR VERSUS SAVR
BALLOON-EXPANDABLE VERSUS SELF-EXPANDING VALVES IN TAVR
COMPLICATIONS OF TAVR
INDIAN SCENARIO
CONCLUSION
CHAPTER 20:
Transcatheter Closure of Congenital Heart Defects
INTRODUCTION
ATRIAL SEPTAL DEFECT
VENTRICULAR SEPTAL DEFECT
Congenital VSDs in Adults
Post-MI Ventricular Septal Rupture (VSR)
Procedure
PATENT DUCTUS ARTERIOSUS
Indications and Contraindications3
RUPTURED SINUS OF VALSALVA ANEURYSM
Procedure
CORONARY ARTERIAL FISTULA
Procedure
RETRIEVAL OF EMBOLIZED DEVICES
CONCLUSION
CHAPTER 21:
Interventions in Hypertrophic Cardiomyopathy
EPIDEMIOLOGY AND PATHOPHYSIOLOGY
ALCOHOL SEPTAL ABLATION
Criteria for Patient Selection and Anatomical Considerations (Table 1)
Procedure
After the Procedure
Pathophysiologic Mechanism of Response to ASA
Complications
Outcome Data
The Debate: Surgical Myectomy versus ASA
ALTERNATIVE APPROACHES FOR SEPTAL ABLATION
PERCUTANEOUS TREATMENT OF MITRAL VALVE FOR OBSTRUCTIVE HCM
CONCLUSION
CHAPTER 22:
Interventions in Pulmonary Embolism
INTRODUCTION
CLASSIFICATION OF PULMONARY EMBOLISM
MANAGEMENT OF PE
Treatment Options
Treatment Algorithm
Anticoagulation
Parenteral Anticoagulation
Oral Anticoagulants
Systemic Thrombolysis
Indications of Thrombolysis
Contraindications for Thrombolysis (Table 5)
Percutaneous Catheter-Directed Interventions
Venous Filters
Types
Procedure
Surgical Embolectomy
Future Perspective
Ultrasound-Assisted Catheter-Directed Thrombolysis
CHAPTER 23:
Recent Advances in Cardiac Electrophysiology
MAPPING TECHNIQUES (Table 1)
ABLATION ENERGY
CATHETERS (Table 2)
ATRIAL FIBRILLATION ABLATION
VENTRICULAR TACHYCARDIA ABLATION
REMOTE NAVIGATION SYSTEMS
CHAPTER 24:
Newer Devices in Electrophysiology: Leadless Pacemakers and Subcutaneous ICD
INTRODUCTION
LEADLESS PACEMAKER
MICRA TRANSCATHETER PACING SYSTEM (TPS)
IMPLANT PROCEDURE (Fig. 5)
CURRENT INDICATIONS FOR THE LEADLESS PACEMAKER
CLINICAL EXPERIENCE
SUMMARY ABOUT LEADLESS PACEMAKER
SUBCUTANEOUS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR (S-ICD)
IMPLANT PROCEDURE (Fig. 7)
EFFICACY AND SAFETY OF THE DEVICE
CURRENT INDICATIONS OF THE S-ICD
LIMITATIONS OF THE S-ICD
SUMMARY ABOUT SUBCUTANEOUS ICD
CONCLUSION
INDEX
TOC
Index
×
Chapter Notes
Save
Clear